Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
about
Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control studyPathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppressionA multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studiesThe prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.Association between the CD28 IVS3 +17T>C (rs3116496) polymorphism and cancer susceptibility: a meta-analysis involving 8,843 subjects.Germline determinants of clinical outcome of cutaneous melanoma.Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.T cell costimulation and coinhibition: genetics and disease.Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Association of Inducible T Cell Costimulator Polymorphisms with Susceptibility and Outcome of Hepatitis B Virus Infection in a Chinese Han Population.CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population.Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.High CTLA-4 expression correlates with poor prognosis in thymoma patients.Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Populationtagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjectsPolymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis
P2860
Q33710123-7F8925EC-C1F9-4B0B-B369-858027247452Q34019536-BA4F1E23-065A-4CE8-BD27-56769C762993Q34117595-DB7FBB71-519D-464F-A553-F9C3A3C02C0BQ34387506-409633BD-0AB0-47CB-8EBA-475596F21EB2Q34651347-817F84CF-FEB2-4A37-9E3D-39B8B8625BCBQ35078169-5695F786-5791-4629-B9F6-56B5095EC3BEQ35870600-3DAE0271-29CB-4E66-A17E-1BD2CA573264Q36283876-CFC788D8-A7EC-4E00-AFB6-7EC18F9749FCQ36411497-2E6ABB6F-C6EE-438F-B377-549D1EC4BAB9Q37258423-BDC218C9-30B5-4A9E-9A55-B93DE2FED982Q37295753-B35A04F1-FECF-418E-AFB4-F7418EC2A31EQ37923993-ED5440C7-A153-4A1A-A229-EB3A452969BBQ38806513-52AE4D29-61EA-414B-8996-75043D9987E3Q40836133-01D63612-EE18-4C50-A3C8-1E216A663138Q41321356-33AC3670-B31F-446E-BD8E-349246B0545EQ41710151-692AAF35-6A19-43D0-B210-B0F888CB8F29Q41975739-ABB45C29-A7D7-48B4-A831-27BA1032ADD7Q50928165-EF2EE92A-049D-4F08-A3F4-4BB3FE0F92A5Q52577907-6D3B221E-815E-49A4-86EF-536513C0EFD3Q54943060-8F796A55-9C47-47EB-91FC-12FF06326870Q55440692-0BE10FDE-9F27-4EBE-ADBD-C66811E71137Q56890294-7F5F6989-2D0E-4D77-BEA4-C59E7859CB68Q56898637-C5F9372F-D06B-4A4B-BA62-F215726C925D
P2860
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@ast
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@en
type
label
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@ast
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@en
prefLabel
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@ast
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@en
P2093
P2860
P50
P1476
Polymorphisms in the CD28/CTLA ...... susceptibility and prognosis?
@en
P2093
Adina Figl
Alexander M M Eggermont
Andreas Gast
Marna G Bouwhuis
P2860
P2888
P304
P356
10.1007/S00262-009-0751-2
P577
2010-02-01T00:00:00Z
P5875
P6179
1007473001